| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5df91b83742bcb8697bc96f405f4b8e8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C317-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C57-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-34 |
| filingDate |
2017-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b2b2075ac5154b33b16a035ff1454ae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0ab7b5da7db634dd638bdac71d651e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_545430a449aa68a4d7238fffb5d4d2cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b32a3ca95e98038c27a4b892e82807d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40ea7e6b6d85926001904a5391658c0a |
| publicationDate |
2018-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201803853-A |
| titleOfInvention |
Salt of 2,6-dimethylpyrimidinone derivative and use thereof |
| abstract |
The invention relates to salts of 2,6-dimethylpyrimidinone derivatives and uses thereof. The present invention also relates to pharmaceutical compositions containing said salts or combinations thereof. The salt of the 2,6-dimethylpyrimidinone derivative or the pharmaceutical composition containing the salt proposed by the present invention can be used to treat and prevent fibrosis diseases of tissues or organs. |
| priorityDate |
2016-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |